SCHEMBL12201997

SCHEMBL12201997

C=C(CC)C(=O)c1ccc(OCC(=O)Nc2ccc3cnccc3c2)c(Cl)c1Cl

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 5/20 0.59
GSTP1 P09211 11/20 0.55
GSTA1 P08263 7/20 0.55
MEN1 O00255 1/20 0.55
ABCC3 O15438 1/20 0.55
PLIN1 O60240 1/20 0.55
ALDH1A1 P00352 1/20 0.55
LMNA P02545 1/20 0.55
TP53 P04637 1/20 0.55
MAPT P10636 1/20 0.55
HSPD1 P10809 1/20 0.55
CYP2C9 P11712 1/20 0.55
TSHR P16473 1/20 0.55
HTT P42858 1/20 0.55
RECQL P46063 1/20 0.55
MAP2K6 P52564 1/20 0.55
HSPE1 P61604 1/20 0.55
GSTO1 P78417 1/20 0.55
PLIN5 Q00G26 1/20 0.55
KMT2A Q03164 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12201988 0.86 NOTUM (0.66) NOTUMMEN1LMNAKMT2AATM
SCHEMBL30755182 0.84 GSTP1 (0.53) NOTUMGSTP1GSTA1MEN1ABCC3
SCHEMBL30755107 0.83 NPC1 (0.58) GSTP1GSTA1MEN1ABCC3PLIN1
SCHEMBL27172578 0.82 NOTUM (0.58) NOTUMGSTP1GSTA1MEN1ABCC3
SCHEMBL30755193 0.81 NOTUM (0.56) NOTUMGSTP1GSTA1MEN1ABCC3
SCHEMBL30755161 0.81 NOTUM (0.58) NOTUMGSTP1GSTA1MEN1ABCC3
SCHEMBL30755136 0.80 GSTP1 (0.56) NOTUMGSTP1GSTA1MEN1ABCC3
SCHEMBL27172592 0.80 GSTP1 (0.56) NOTUMGSTP1GSTA1MEN1ABCC3
SCHEMBL30755213 0.80 NOTUM (0.56) NOTUMGSTP1GSTA1MEN1ABCC3
SCHEMBL27172563 0.80 NOTUM (0.56) NOTUMGSTP1GSTA1MEN1ABCC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8034943-B2 6-aminoisoquinoline compounds AERIE PHARMACEUTICALS, INC. (US) 2011-10-11 US disclosed
US-8034943-B2 6-aminoisoquinoline compounds AERIE PHARMACEUTICALS, INC. (US) 2011-10-11 US disclosed
US-20100137364-A1 6-Aminoisoquinoline Compounds AERIE PHARMACEUTICALS, INC. (US) 2010-06-03 US disclosed
US-20100137364-A1 6-Aminoisoquinoline Compounds AERIE PHARMACEUTICALS, INC. (US) 2010-06-03 US disclosed
US-7671205-B2 6-aminoisoquinoline compounds AERIE PHARMACEUTICALS, INC. (US) 2010-03-02 US disclosed
US-7671205-B2 6-aminoisoquinoline compounds AERIE PHARMACEUTICALS, INC. (US) 2010-03-02 US disclosed
US-20070173530-A1 6-Aminoisoquinoline Compounds AERIE PHARMACEUTICALS, INC. (US) 2007-07-26 US disclosed
US-20070173530-A1 6-Aminoisoquinoline Compounds AERIE PHARMACEUTICALS, INC. (US) 2007-07-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100137364-A1 6-Aminoisoquinoline Compounds COQ8A, PGC, AGK NOTUM 3635/4885GSTP1 964/4885GSTA1 1372/4885
US-20070173530-A1 6-Aminoisoquinoline Compounds COQ8A, PGC, AGK NOTUM 3635/4885GSTP1 964/4885GSTA1 1372/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.